Bispecific EGFR/HER3-targeted antibody-drug conjugate that binds EGFR and HER3, undergoes receptor-mediated internalization, and releases a camptothecin-class topoisomerase I inhibitor payload, causing replication-associated DNA damage and apoptosis in tumor cells.